SCHEMBL24674969

SCHEMBL24674969

O=C1Nc2cc(C(F)(F)F)cnc2N2CCNC[C@H]12

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 16/20 0.53
HTR2A P28223 6/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HTR2B P41595 4/20 0.41
CBLB Q13191 1/20 0.41
TIPARP Q7Z3E1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675535 1.00 HTR2C (0.53) HTR2CHTR2AALDH1A1CYP1A2CYP3A4
SCHEMBL24674699 1.00 HTR2C (0.53) HTR2CHTR2AALDH1A1CYP1A2CYP3A4
SCHEMBL31245455 0.88 HTR2C (0.43) HTR2CHTR2AALDH1A1CYP1A2CYP3A4
SCHEMBL24675334 0.85 HTR2C (0.56) HTR2CHTR2AALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL30658102 0.84 HTR2C (0.55) HTR2CHTR2AALDH1A1CYP1A2CYP3A4
SCHEMBL31245115 0.82 KMT2A (0.63) ALDH1A1KMT2AMEN1KDM4EMAPT
SCHEMBL30729642 0.81 HTR2C (0.45) HTR2CHTR2ACYP3A4HTR2B
SCHEMBL24674980 0.81 HTR2C (0.50) HTR2CHTR2AHTR2B
SCHEMBL26915100 0.81 HTR2C (0.45) HTR2CHTR2ACYP3A4HTR2B
SCHEMBL31245229 0.81 HTR2C (0.48) HTR2CHTR2ACYP3A4HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289845-A1 TRIHETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Apeiron Therapeutics Company Limited (CN) 2023-12-13 EP disclosed
EP-4289845-A1 TRIHETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Apeiron Therapeutics Company Limited (CN) 2023-12-13 EP disclosed
WO-2022223022-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2022-10-27 WO disclosed